Top news of the week: 22.04.2022.
Career And Jobs
Better Together: Biopharma Companies Team Up Against Complex Diseases
Global biopharmaceutical companies are pooling their respective resources against difficult-to-treat tumors, CNS diseases and idiopathic pulmonary fibrosis.
Biotech Tries Manipulating the Skin Microbiome
Researchers are revealing the complexity of the microbial community living on the body—and paving the way for new bacteria-targeting treatments for acne and other dermatological conditions.
Zooming in on a biotech layoff; $1.9B buyout to fill M&A void; Covid winners appoint new finance chiefs; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader ...
Regeneron buys Art Krieg’s biotech startup for a discount price, boosting I/O pipeline
Jumping into the M&A game, Regeneron has scooped up a beaten down Checkmate Pharmaceuticals for $250 million in cash, bagging its lead drug for melanoma. That’s almost 5 times the Art Krieg ...
Sanofi Strikes Deal With Mysterious Psychedelics Biotech Terran
New York-based Terran Biosciences inked a deal with Paris-based Sanofi for two late-stage central nervous system (CNS) assets. Terran plans to advance them for neurological and ...
Rejuveron CEO and Co-Founder Matthias Steger named as a 2022 In Vivo Rising Leader
Rejuveron Life Sciences AG (‘Rejuveron’), a Zürich-based biotechnology company developing therapies to promote healthy aging, is delighted to announce that its CEO ...
New 16-Story Life Sciences Hub to Bolster Burgeoning Chicago Hub
The new building will suit multiple life sciences industry segments, including biopharma, medtech, agroscience and more.
PHASTAR Names Ping-Chung Chang as Head of China Development and Global Delivery
Beijing, China and London, UK, April 20, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, ...